TIM-3 was found in approximately 6% of the bone marrow T cells in newly diagnosed AML patients, and the proportion was larger (11.5–18.5%) in FLT3-ITD mutated cases [33]. This evidence concerns the gene FLT3 and acute myeloid leukemia.